Effect of racial disparities on cancer survival in hematologic malignancies: a population-based analysis of SEER data (2009–2019) by Alma Habib, Ying Huang, Electra D. Paskett, Srinivas Devarakonda, James L. Fisher, Adam S. Kittai

Subjects: “…Hematologic malignancy…”
Get full text

Clinical characteristics and prognostic factors of sepsis in patients with malignancy by Green Hong, Hyekyeong Ju, Dong Kyu Oh, Su Yeon Lee, Mi Hyeon Park, Haein Lee, Chae-Man Lim, Song I Lee, The Korean Sepsis Alliance (KSA) investigators

Subjects: Get full text

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA by Cumali Yalçın, Fahir Özkalemkaş, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Merve Nur Akyol, Nevriye Gül Ada, Cüneyt Özakın, Esra Kazak, Halis Akalın, Rıdvan Ali

Subjects: Get full text

Trends and outcomes of chemotherapy timing in critically ill patients with hematologic malignancies using a Japanese national database by Yudai Iwasaki, Kunio Tarasawa, Tadashi Kamio, Yu Kaiho, Saori Ikumi, Shizuha Yabuki, Kiyohide Fushimi, Kenji Fujimori, Masanori Yamauchi

Subjects: Get full text

Potential Drug Interactions in Hospitalized Hematologic Cancer Patients: New Update with New Chemotherapy Regimens by Tahereh Gholipourshahraki, Amir Aria, Mehran Sharifi, Ayda Moghadas, Azadeh Moghaddas

Subjects: Get full text

Can Bacillus paranthracis cause bacteremia in a T-ALL patient? WGS-based diagnosis by Serap Süzük Yıldız, Ayşegül Polat, Süleyman Yalçın, Mert Emre Ölmez, Tahir Darçın, Kerem Özdel, İpek Mumcuoğlu, Tuba Dal

Subjects: Get full text

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies by Tara Murty, Jonathan H. Lin, Prithvi Mruthyunjaya

Subjects: Get full text

Analysis of coinfections in patients with hematologic malignancies and COVID-19 by next-generation sequencing of bronchoalveolar lavage fluid by Wenxiu Shu, Qianqian Yang, Jing Le, Qianqian Cai, Hui Dai, Liufei Luo, Jiaqi Tong, Yanping Song, Bingrong Chen, Yaodong Tang, Dian Jin

Subjects: Get full text

Antiviral combination treatment of SARS-CoV-2 after repeated treatment failures of remdesivir monotherapy: A case report by Anne Cathrine Bay, Michael R. Clausen, Birgit Thorup Røge, Thomas V. Sydenham, Kat Steinke, Rune Micha Pedersen, Line L. Bang, Thomas E. Andersen, Anders Jensen, Lone W. Madsen

Subjects: Get full text

Prenatal diagnosis and genetic counseling of mosaicism for chromosome t (7; 14) with a favorable outcome by D. Lu, D. Cao, Q. Zhao, X. Chen

Subjects: Get full text

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma by Dan Liu, Xia Yin, Hui Wang, Lijie Xing, Ping Li, Haichen Wei, Ji Ma, Qiang He, Linna Xie, Ke Lu, Zengjun Li

Subjects: Get full text

Impact of hospital variation in hematologic malignancy patient proportions on outcomes of chronic lymphocytic leukemia patients undergoing cardiac surgery: insights from nationwide... by Meizhen Yi, Lanxin Hu, Jifang Zhou, Yali Ge, Cunhua Su, Fan Yang

Subjects: Get full text

Latent profile analysis of fear of progression in Chinese hematologic malignancy survivors by Yating Liu, Qianqian Zhang, Jinying Zhao, Tiantian Zhang, Fei Tian, Zhixin Wang, Zhuli Shao, Xiaobin Li, Wenjun Xie, Fan Yang, Qiuyan Li, Junjie Li

Subjects: “…Hematologic malignancy…”
Get full text

Research progress of GALNT3 as a potential tumor molecular marker and drug target by GAO Yixuan, ZHANG Yichi, DAI Luyan, MA Jiao

Subjects: Get full text

CRISPR-Cas9 in basic and translational aspects of cancer therapy by Maryam Samareh Salavatipour, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei

Subjects: Get full text

Radiation Therapy for Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Review of the Literature by Masashi Taka, Shinichiro Toyoshima, Shigeyuki Takamatsu, Satoshi Kobayashi

Subjects: Get full text

Secondary infections after cytotoxic chemotherapy in patient with hematological malignancies by Seyit Ali Büyüktuna, Rabin Saba, Mustafa Gökhan Gözel, Özge Turhan, Dilara İnan, Zahide Aşık, Adem Köse

Subjects: “…hematological malignancy…”
Get full text

Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective by Paul Loubet, Ilies Benotmane, Slim Fourati, Florent Malard, Fanny Vuotto, Elodie Blanchard, François Raffi, Stéphanie Nguyen, Nicolas de Prost, Jérôme Avouac

Subjects: Get full text

ORGANIZATION OF REHABILITATION ASSISTANCE TO CHILDREN WITH SEVERE DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS by N. G. Petrova, V. M. Khabibulina, E. A. Khasanova

Subjects: “…children with hematologic malignancies…”
Get full text

A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab by Daniel Thomas Jones, Hazem Aboaid, Ramaditya Srinivasmurthy, Kevin Nguyen, Rishi Kumar Nanda, Jason Ta, Benjamin Tzer-Ming Chuang, Yin Mon Myat, Aishwarya Hanspal, Kyaw Zin Thein, Thura Win Htut

Subjects: Get full text